Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Søren Møller, Karen V. Danielsen, Puria Nabilou, Nina Kimer & Flemming Bendtsen. (2023) Beta-adrenergic blockade in cirrhosis – harmful or helpful?. Expert Review of Gastroenterology & Hepatology 17:6, pages 519-529.
Read now
Read now
Søren Møller, Aleksander Krag, Jens H. Henriksen & Flemming Bendtsen. (2007) Pathophysiological aspects of pulmonary complications of cirrhosis. Scandinavian Journal of Gastroenterology 42:4, pages 419-427.
Read now
Read now
Søren Møller, Flemming Bendtsen & Jens H. Henriksen. (2006) Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume. Scandinavian Journal of Gastroenterology 41:4, pages 451-458.
Read now
Read now
Søren Møller, Flemming Bendtsen & Jens H. Henriksen. (2005) Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scandinavian Journal of Gastroenterology 40:5, pages 491-500.
Read now
Read now
J. H. Henriksen. (2004) Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 64:6, pages 523-534.
Read now
Read now
J. H. Henriksen, V. Gülberg, A. L. Gerbes, F. Bendtsen & S. Møller. (2003) Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide. Scandinavian Journal of Gastroenterology 38:5, pages 559-564.
Read now
Read now
Articles from other publishers (11)
Jens H. Henriksen & Søren Møller. (2013) Ascites. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 5:1, pages 1-116.
Crossref
Crossref
Elaine M. Fisher & Diane K. Brown. (2010) Hepatorenal Syndrome. AACN Advanced Critical Care 21:2, pages 165-184.
Crossref
Crossref
Zekanovic Drazen, Ljubicic Neven, Boban Marko, Nikolic Marko, Delic-Brkljacic Diana, Gacina Petar, Klarin Ivo & Turcinov Jadranko. (2009) Doppler Ultrasound of Hepatic and System Hemodynamics in Patients with Alcoholic Liver Cirrhosis. Digestive Diseases and Sciences 55:2, pages 458-466.
Crossref
Crossref
Puneeta Tandon, Ross T. Tsuyuki, Lesley Mitchell, Michael Hoskinson, Mang M. Ma, Winnie W. Wong, Andrew L. Mason, Klaus Gutfreund & Vincent G. Bain. (2009) The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study. Liver International 29:2, pages 169-174.
Crossref
Crossref
Elena Mancini & Antonio Santoro. 2009. Critical Care Nephrology. Critical Care Nephrology
1040
1047
.
Søren Møller, Jens H. Henriksen & Flemming Bendtsen. (2008) Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatology International 2:4, pages 416-428.
Crossref
Crossref
Søren Møller. (2006) Cardiopulmonary complications in chronic liver disease. World Journal of Gastroenterology 12:4, pages 526.
Crossref
Crossref
Søren Møller & Jens Henriksen. 2005. Ascites and Renal Dysfunction in Liver Disease. Ascites and Renal Dysfunction in Liver Disease
137
155
.
S. Møller & J. H. Henriksen. (2004) Pathogenesis and pathophysiology of hepatorenal syndrome - is there scope for prevention?. Alimentary Pharmacology & Therapeutics 20, pages 31-41.
Crossref
Crossref
James N. Welch & Susan A. Chrysogelos. 2002. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
65
79
.
Yaacov Baruch, Nimer Assy, Felix Weisbruch, Shimon A Reisner, Diana Rinkevich, Rafael Enat, Lawrence M Blendis & Arieh Bomzon. (1999) A Pilot Study on The Hemodynamic Effect of Short-Term Ursodeoxycholic Acid Therapy in Patients With Stable Liver Cirrhosis. American Journal of Gastroenterology 94:10, pages 3000-3004.
Crossref
Crossref